These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38988558)

  • 1. Comprehensive molecular analyses and experimental validation of CDCAs with potential implications in kidney renal papillary cell carcinoma prognosis.
    Li F; Wu Z; Du Z; Ke Q; Fu Y; Zhan J
    Heliyon; 2024 Jun; 10(12):e33045. PubMed ID: 38988558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Medicine (Baltimore); 2022 Feb; 101(5):e28788. PubMed ID: 35119046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma.
    Wu B; Huang Y; Luo Y; Ma A; Wu Z; Gan Y; Xu Y; Xu R
    J Cancer; 2020; 11(19):5727-5737. PubMed ID: 32913466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analysis of the Clinical Relevance of Cell Division Cycle Associated Family in Endometrial Carcinoma.
    Zhang W; Qiu X; Sun D; Zhang D; Qi Y; Li X; Liu B; Liu J; Lin B
    J Cancer; 2020; 11(19):5588-5600. PubMed ID: 32913454
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
    Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
    Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
    Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
    BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma.
    Wang Y; Yang Y; Gao H; Ouyang T; Zhang L; Hu J; Hu S; Kan H
    Front Oncol; 2020; 10():566183. PubMed ID: 33665158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
    Li R; Chen Y; Yang B; Li Z; Wang S; He J; Zhou Z; Li X; Li J; Sun Y; Guo X; Wang X; Wu Y; Zhang W; Guo G
    PLoS One; 2024; 19(1):e0295346. PubMed ID: 38181024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
    Wang Z; Xu J; Zhang S; Chang L
    Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients.
    Meng J; Gao L; Zhang M; Gao S; Fan S; Liang C
    Biomark Med; 2020 Feb; 14(3):223-238. PubMed ID: 31955607
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 13. CDCA gene family promotes progression and prognosis in lung adenocarcinoma.
    Liu X; Zhu X; Zhao Y; Shan Y; Gao Z; Yuan K
    Medicine (Baltimore); 2024 Jun; 103(24):e38581. PubMed ID: 38875380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
    Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
    BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.
    Phan NN; Wang CY; Li KL; Chen CF; Chiao CC; Yu HG; Huang PL; Lin YC
    Oncotarget; 2018 Jan; 9(6):6977-6992. PubMed ID: 29467944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
    Kang Z; Yang J
    J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
    Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
    Fei H; Chen S; Xu C
    BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.